# US 6,731,965 B2 · Corrosion prevention in biomedical electrodes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,731,965 B2
- Document ID: US6731965B2
- Status: Granted
- Kind: B2
- Application number: 09/885,025
- Filed: 2001-06-20
- Published: 2003-03-06
- Granted: 2004-05-04
- Earliest claimed: 2001-06-20
- Assignees: 3M Innovative Properties Company
- Inventors: Vinod P. Menon; Hatim M. Carim
- Web page: https://patentgrep.com/patent/US6731965B2

## CPC

- A61B 5/265: containing silver or silver chloride
- A61B 5/259: using conductive adhesive means, e.g. gels
- A61B 2562/0215: Silver or silver chloride containing
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A non-polarizable, silver/silver chloride biomedical electrode that is protected against corrosion during its shelf life by an organic corrosion retarding agent, preferably selected from the group consisting of mercaptans and azoles.

## Claims

### Claim 1

A biomedical electrode comprising a conductor in contact with a conductive medium, wherein the conductor comprises a conductively active source of at least partially chlorided silver and wherein the electrode further comprises at least one organic corrosion retarding agent present in an amount of at least 0.01 percent by weight of elemental silver in the conductor.

### Claim 2 (depends on 1)

The biomedical electrode of claim 1 wherein the conductor comprises a polymeric material in the form of a film upon one side of which is disposed a layer of partially chlorided silver.

### Claim 3 (depends on 1)

The biomedical electrode of claim 1 wherein the conductor comprises a graphite loaded polymer.

### Claim 4 (depends on 1)

The biomedical electrode of claim 1 wherein the conductor comprises a graphite loaded polymer in the form of a stud upon the outer surface of which is disposed a layer of partially chlorided silver.

### Claim 5 (depends on 1)

The biomedical electrode according to claim 1 wherein the organic corrosion retarding agent is selected from the group consisting of mercaptans and azoles.

### Claim 6 (depends on 1)

The biomedical electrode according to claim 1 wherein the agent is present in an amount between about 0.1 percent and 1.0 percent by weight of elemental silver in the conductor.

### Claim 7 (depends on 1)

The biomedical electrode according to claim 1 wherein the agent is present in an amount between about 0.3 percent and 0.5 percent by weight of elemental silver in the conductor.

### Claim 8 (depends on 1)

The biomedical electrode according to claim 1 wherein the conductor comprises a backing having silver/silver chloride containing ink thereon.

### Claim 9

A biomedical electrode, comprising a conductor in contact with a conductive medium, wherein the conductor comprises a substrate having at least partially chlorided silver thereon, wherein the silver has been treated with an organic corrosion retarding agent.

### Claim 10 (depends on 9)

The biomedical electrode according to claim 9 wherein the organic corrosion retarding agent is selected from the group consisting of mercaptans and azoles.

### Claim 11 (depends on 9)

The biomedical electrode according to claim 9 wherein the agent is present in an amount of at least 0.01 percent by weight of elemental silver in the conductor.

### Claim 12 (depends on 9)

The biomedical electrode according to claim 9 wherein the agent is present in an amount between about 0.1 percent and 1.0 percent by weight of elemental silver in the conductor.

### Claim 13 (depends on 9)

The biomedical electrode according to claim 9 wherein the agent is present in an amount between about 0.3 percent and 0.5 percent by weight of elemental silver in the conductor.

### Claim 14 (depends on 9)

The biomedical electrode according to claim 9 wherein the conductor comprises a backing having silver/silver chloride containing ink thereon.

### Claim 15 (depends on 9)

The biomedical electrode according to claim 9 wherein the agent is selected the group consisting of 2-mercaptobenzoxazole and octadecanethiol.

### Claim 16

A method of preparing a biomedical electrode, comprising the steps of:
preparing a conductor having a conductive layer comprising partially chlorided silver and at least one organic corrosion retarding agent; and
applying a layer of conductive medium to the conductive layer.

### Claim 17 (depends on 16)

The method according to claim 16 wherein the conductor comprises a backing having a silver/silver chloride ink thereon.

### Claim 18 (depends on 16)

The method of preparing a biomedical electrode according to claim 16 wherein the agent is selected the group consisting of mercaptans and azoles.

### Claim 19 (depends on 16)

The method of preparing a biomedical electrode according to claim 16 wherein the agent is selected from the group consisting of 2-mercaptobenzoxazole and octadecanethiol.

### Claim 20 (depends on 16)

The biomedical electrode according to claim 16 wherein the agent is present in an amount of at least 0.01 percent by weight of elemental silver in the conductor.

### Claim 21 (depends on 16)

The biomedical electrode according to claim 16 wherein the agent is present in an amount between about 0.1 percent and 1.0 percent by weight of elemental silver in the conductor.

### Claim 22 (depends on 16)

The biomedical electrode according to claim 16 wherein the agent is present in an amount between about 0.3 percent and 0.5 percent by weight of elemental silver in the conductor.
